You’re studying the net version of STAT’s Well being Tech e-newsletter, our information to how expertise is remodeling the life sciences. Signal as much as get it delivered in your inbox each Tuesday and Thursday.
Katie Palmer braved frigid temperatures in Chicago final week to be taught concerning the scorching, scorching world of utilizing synthetic intelligence to investigate medical imaging on the Radiological Society of North America annual assembly. She’s already delivered two good readouts:
- Radiology was an early adopter of AI expertise however as researchers and startups forge forward lean with a brand new wave of the expertise, practices and are nonetheless scrambling to meet up with the older era of tech. Learn extra right here.
- With the rise of huge imaginative and prescient fashions that may carry out broader interpretation of imaging like chest X-Rays, there’s a rising debate about how a lot work ought to be offloaded to AI — particularly given the scarcity of radiologists. Learn extra right here.
Schizophrenia DTx is headed to FDA
Talking of frigid temperatures, final week I drove 60 terrifying, snowy miles on uncleared Vermont freeway to attend a digital well being summit at Dartmouth Faculty’s Heart for Expertise and Behavioral Well being. On prime of some very attention-grabbing views on AI regulation all through the day, the spotlight was the primary U.S. presentation of knowledge from an RCT of an experimental digital therapeutic, CT-155, that treats unfavourable signs of schizophrenia, together with lack of motivation and the shortcoming to really feel pleasure.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.